Biotech

Biotech Dates to Remember

 

Successful biotech investors keep a close eye on the calendar. Regulatory decisions and clinical trial results move this sector, so it's important to stay on top of these events whenever possible.

Scores of readers have emailed me requesting a biotech catalyst calendar. As I always aim to please, I've put one together for you, culling important dates from a variety of sell-side analyst notes, as well as from BioMedTracker.com, a drug research service from Sagient Research (a great resource, if you can afford it).

I tried to cover as many companies and events as I could in this 2007 calendar, but in the interest of brevity, I kept descriptions here to a minimum.

I'm sure there are companies and events that are missing here; I didn't intend this calendar to be comprehensive, but I do believe it hits all the big targets.

Enjoy -- I hope this helps your biotech investing. (Click here to view Adam's 2007 biotech calendar. )

>To order reprints of this article, click here: Reprints

Adam Feuerstein writes regularly for RealMoney.com. In keeping with TSC's editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet.com. He also doesn't invest in hedge funds or other private investment partnerships. Feuerstein appreciates your feedback; click here to send him an email.

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,419.86 1,313.32 2,837.36 16.00
Oil *
103.16
DOWN
160.83
DOWN
19.10
DOWN
33.63
DOWN
0.25
10 Yr
1.60%
SPDR Gold
151.91
-1.28%
-1.43%
-1.17%
-1.54%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet